Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Biochim Biophys Acta Mol Basis Dis. 2019 Oct 19;1866(1):165561. doi: 10.1016/j.bbadis.2019.165561

Fig. 1. RAD6B is overexpressed in BRCA1 wild-type and mutant TNBCs and overexpression correlates with poor overall survival.

Fig. 1.

(A) Immunohistochemical, (B) immunofluorescence and western blot analysis of RAD6. Original magnification for panels a, c, d in A is ×20, and for panel b in A is ×40. Scale bars for MDA-MB-231, SUM1315, MDA-MB-468 and MCF10A cell, 10 μm; scale bar in HCC1937 panel, 20 μm. (C,D) RAD6A and RAD6B copy number, and (E) association with TNBC patient survival (N = 594).